Fig. 1From: Novel drugs that target the metabolic reprogramming in renal cell cancerAn overview of the molecular players in the metabolism of glucose, fatty acids, and glutamine. Pathways were divided in five different sections based on recognition as different entity in biochemical literature. Molecules labeled green were found to be upregulated in RCC specimens, while red molecules were downregulatedBack to article page